FDA Approved: ONDANSETRON — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approves Eugia US LLC's original application for ondansetron hydrochloride, granting generic approval for this antiemetic under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

ORIG AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)